cyclosporine has been researched along with Xerophthalmia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dana, R; Dastjerdi, MH; Hamrah, P | 1 |
Baudouin, C; Brignole, F; Pisella, PJ | 1 |
Sun, J; Wang, J | 1 |
Brown, MJ; Hardten, DR; Pham-Vang, S | 1 |
Collum, LM; Farrell, M; Mullaney, P; Power, WJ | 1 |
1 review(s) available for cyclosporine and Xerophthalmia
Article | Year |
---|---|
[Current treatments of xerophthalmia in Sjögren's syndrome].
Topics: Administration, Topical; Anti-Infective Agents, Local; Cyclosporine; Gels; Humans; Immunosuppressive Agents; Miotics; Ophthalmic Solutions; Pilocarpine; Product Packaging; Sjogren's Syndrome; Xerophthalmia | 2004 |
1 trial(s) available for cyclosporine and Xerophthalmia
Article | Year |
---|---|
Evaluation of an isotonic tear in combination with topical cyclosporine for the treatment of ocular surface disease.
Topics: Administration, Topical; Aged; Cyclosporine; Epithelium, Corneal; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Treatment Outcome; Xerophthalmia | 2007 |
3 other study(ies) available for cyclosporine and Xerophthalmia
Article | Year |
---|---|
High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen.
Topics: Administration, Topical; Adult; Aged; Cohort Studies; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorescein; Fluorescent Dyes; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Retreatment; Retrospective Studies; Severity of Illness Index; Sjogren's Syndrome; Staining and Labeling; Xerophthalmia | 2009 |
Cyclosporine inhibits apoptosis in experimental murine xerophthalamia conjunctival epithelium.
Topics: Administration, Topical; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Conjunctiva; Cyclosporine; Epithelium; Female; Immunohistochemistry; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Ophthalmic Solutions; Proto-Oncogene Proteins c-bcl-2; Scopolamine; Xerophthalmia | 2006 |
Effect of topical cyclosporin A on conjunctival T cells in patients with secondary Sjögren's syndrome.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Conjunctiva; Cyclosporine; Female; Humans; Leukocyte Count; Male; Middle Aged; Ophthalmic Solutions; Sjogren's Syndrome; T-Lymphocyte Subsets; Xerophthalmia | 1993 |